|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Departments of Anesthesiology and General Intensive Care, University of Vienna, Vienna, Austria
2 From the Department of Pulmonary Medicine, University of Vienna, Vienna, Austria
3 From the Department of Anesthesiology, College of Physicians and Surgeons of Columbia University, New York
Study objective: To assess the effect of nitric oxide inhalation on pulmonary hemodynamics and oxygenation in patients with COPD receiving long-term oxygen therapy (LTOT).
Design: Prospective study.
Setting: ICU of a university medical center.
Patients: A total of 18 (6 female, 12 male) patients with COPD, spontaneously breathing with LTOT.
Interventions: Oxygenation and hemodynamic variables were measured and calculated at an inspired oxygen fraction (FIO2) adjusted to mimic LTOT conditions (control), and then 1 h after each sequential addition of 5, 10, and 20 ppm nitric oxide to the gas mixture. A newly developed device (Pulmonox) provided both the delivery and continuous analysis of nitric oxide and oxidative nitric oxide products.
Measurements and results: There was a significant improvement in oxygenation at 5 ppm nitric oxide (PaO2/FIO2 ratio improved from 244±37 to 303±59, p<0.05), but no further improvement at higher doses (ceiling effect). There was a dose-dependent improvement in hemodynamic variables that was maximal at 20 ppm nitric oxide (mean pulmonary artery pressure decreased from 29±7 to 24±5 mm Hg, pulmonary vascular resistance index decreased from 565±321 to 392±215 dyne · s · cm
5 · m
2, and right ventricular ejection fraction improved from 34±6 to 39±7%, all p<0.05).
Conclusion: Prior studies have demonstrated that inhaled nitric oxide may improve or worsen oxygenation in patients with COPD. Our data show an unequivocal improvement in oxygenation (albeit with a ceiling effect at 5 ppm) and pulmonary hemodynamics (dose dependent) in COPD patients receiving LTOT. Further studies are warranted to examine the usefulness of inhaled nitric oxide during acute exacerbations of COPD, or even the possibility of long-term application in patients receiving LTOT.
Key Words: COPD long-term oxygen therapy nitric oxide pulmonary hypertension
Submitted on July 8, 1997
Accepted on December 2, 1997
This article has been cited by other articles:
![]() |
M. C. Lanner, M. Raper, W. M. Pratt, and R. A. Rhoades Heterotrimeric G Proteins and the Platelet-Derived Growth Factor Receptor-{beta} Contribute to Hypoxic Proliferation of Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., October 1, 2005; 33(4): 412 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.A. Barbera, V.I. Peinado, and S. Santos Pulmonary hypertension in chronic obstructive pulmonary disease Eur. Respir. J., May 1, 2003; 21(5): 892 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Pepke-Zaba and N W Morrell Pulmonary hypertension in patients with COPD: NO treatment? Thorax, April 1, 2003; 58(4): 283 - 284. [Full Text] [PDF] |
||||
![]() |
K Vonbank, R Ziesche, T W Higenbottam, L Stiebellehner, V Petkov, P Schenk, P Germann, and L H Block Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD Thorax, April 1, 2003; 58(4): 289 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sticher, S. Scholz, O. Boning, R. T. Schermuly, C. Schumacher, D. Walmrath, and G. Hempelmann Small-Dose Nitric Oxide Improves Oxygenation During One-Lung Ventilation: An Experimental Study Anesth. Analg., December 1, 2002; 95(6): 1557 - 1562. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ashutosh, K. Phadke, J. F. Jackson, and D. Steele Use of nitric oxide inhalation in chronic obstructive pulmonary disease Thorax, February 1, 2000; 55(2): 109 - 113. [Abstract] [Full Text] |
||||
![]() |
M. Das, E. C. Dempsey, D. Bouchey, M. E. Reyland, and K. R. Stenmark Chronic Hypoxia Induces Exaggerated Growth Responses in Pulmonary Artery Adventitial Fibroblasts . Potential Contribution of Specific Protein Kinase C Isozymes Am. J. Respir. Cell Mol. Biol., January 1, 2000; 22(1): 15 - 25. [Abstract] [Full Text] |
||||
![]() |
A. L. Cooper and D. Beasley Hypoxia stimulates proliferation and interleukin-1alpha production in human vascular smooth muscle cells Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1326 - H1337. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |